P2 receptors and extracellular ATP: A novel homeostatic pathway in inflammation

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 4, 2011, Pages 1443-1456

  Leo Bours, Martijn Jan ^a   Dagnelie, Pieter Cornelis ^a   Giuliani, Anna Lisa ^b,c   Wesselius, Anke ^a   Di Virgilio, Francesco ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF FERRARA   (Italy)

^c Interdisciplinary Center for the Study in Inflammation   (Italy)

Author keywords

ATP; Inflammation; P2 receptors; Purinergic signalling; Review

Indexed keywords

ADENOSINE TRIPHOSPHATE; CRYOPYRIN; PURINERGIC P2 RECEPTOR; CARRIER PROTEIN; INFLAMMASOME; NLRP3 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; CONCENTRATION (PARAMETERS); CYTOKINE RELEASE; DOWN REGULATION; EXTRACELLULAR SPACE; HOMEOSTASIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; METABOLISM; NONHUMAN; OSTEOPOROSIS; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CHEMISTRY; PHYSIOLOGY; REVIEW;

ANIMALIA;

ADENOSINE TRIPHOSPHATE; CARRIER PROTEINS; EXTRACELLULAR SPACE; HUMANS; INFLAMMASOMES; INFLAMMATION; MODELS, BIOLOGICAL; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 80053100071     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. M. J. Bours, E. L. Swennen, F. Di Virgilio, B. N. Cronstein and P. C. Dagnelie: Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther, 112(2), 358-404 (2006)
2. F. Di Virgilio, J.-M. Boeynaems and S. C. Robson: Extracellular nucleotides as negative modulators of immunity. Curr Opin Pharmacol, 9(4), 507-13 (2009)
3. K. Lohmann: Über die Pyrophosphatfraktion im Muskel Naturwissenschaften, 17(31), 624-5 (1929)
4. F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi and O. R. Baricordi: Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood, 97(3), 587-600 (2001)
5. G. Burnstock: Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev, 58(1), 58-86 (2006)
6. E. Llaudet, S. Hatz, M. Droniou and N. Dale: Microelectrode biosensor for real-time measurement of ATP in biological tissue. Anal Chem, 77(10), 3267-73 (2005)
7. P. Pellegatti, S. Falzoni, P. Pinton, R. Rizzuto and F. Di Virgilio: A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol Biol Cell, 16(8), 3659-65 (2005)
8. P. Pellegatti, L. Raffaghello, G. Bianchi, F. Piccardi, V. Pistoia and F. Di Virgilio: Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One, 3(7), e2599 (2008)
9. K. Wilhelm, J. Ganesan, T. Muller, C. Durr, M. Grimm, A. Beilhack, C. Krempl, S. Sorichter, U. V. Gerlach, E. Juttner, A. Zerweck, Gartner, F., P. Pellegatti, D. Ferrari, F. Di Virgilio, N. Kambham, P. Fisch, J. Finke, M. Idzko and R. Zeiser: Graft-versus-host disease enhanced by extracellular adenosine triphosphate activating P2X7R. Nat Med, 16(12), 1434-8 (2010)
10. F. C. Weber, P. R. Esser, T. Muller, J. Ganesan, P. Pellegatti, M. M. Simon, R. Zeiser, M. Idzko, T. Jakob and S. F. Martin: Lack of purinergic receptor P2X7 results in resistance to contact hypersensitivity. J Exp Med, 207(12), 2609-19 (2010)
11. H. Zimmermann: Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol, 362(4-5), 299-309 (2000)
12. G. G. Yegutkin: Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochimica et Biophysica Acta, 1783(5), 673-94 (2008)
13. C. Nathan: Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol, 6(3), 173-82 (2006)
14. J. Meshki, F. Tuluc, O. Bredetean, Z. Ding and S. P. Kunapuli: Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. Am J Physiol Cell Physiol, 286(2), C264-71 (2004)
15. J. T. O'Flaherty and J. F. Cordes : Human neutrophil degranulation responses to nucleotides. Lab Invest, 70(6), 816-21 (1994)
16. E. Melloni, S. Pontremoli, F. Salamino, B. Sparatore, M. Michetti, O. Sacco and B. L. Horecker: ATP induces the release of a neutral serine proteinase and enhances the production of superoxide anion in membranes from phorbol ester-activated neutrophils. J Biol Chem, 261(25), 11437-9 (1986)
17. B. A. Walker, B. E. Hagenlocker, V. K. Douglas, S. J. Tarapchak and P. A. Ward: Nucleotide responses of human neutrophils. Lab Invest, 64(1), 105-12 (1991)
18. Y. Chen, R. Corriden, Y. Inoue, L. Yip, N. Hashiguchi, A. Zinkernagel, V. Nizet, P. A. Insel and W. G. Junger: ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science, 314, 1792-5 (2006)
19. R. Corriden, Y. Chen, Y. Inoue, G. Beldi, S. C. Robson, P. A. Insel and W. G. Junger: Ecto-nucleoside Triphosphate Diphosphohydrolase 1 (E-NTPDase1/CD39) Regulates Neutrophil Chemotaxis by Hydrolyzing Released ATP to Adenosine. J. Biol. Chem., 283(42), 28480-6 (2008)
20. F. Ben Yebdri, F. Kukulski, A. Tremblay and J. Sevigny: Concomitant activation of P2Y2 and P2Y6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. Eur J Immunol, 39, 2885-94 (2009)
21. M. C. Hyman, D. Petrovic-Djergovic, S. H. Visovatti, H. Liao, S. Yanamadala, D. Bouis, E. J. Su, D. A. Lawrence, M. J. Broekman, A. J. Marcus and D. J. Pinsky: Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest, 119, 1136-49 (2009)
22. D. J. Pinsky, M. J. Broekman, J. J. Peschon, K. L. Stocking, T. Fujita, R. Ramasamy, E. S. J. Connolly, H. J., S. Kiss, Y. Zhang, T. F. Choudhri, R. A. McTaggart, H. Liao, J. H. Drosopoulos, V. L. Price, A. J. Marcus and C. R. Maliszewski: Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest, 109(8), 1031-40 (2002)
23. L. Belayev, L. Khoutorova, T. A. Deisher, A. Belayev, R. Busto, Y. Zhang, W. Zhao and M. D. Ginsberg: Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke, 34(3), 758-63 (2003)
24. A. Grenz, H. Zhang, H. Hermes, T. Eckle, K. Klingel, D. Huang, C. E. Muller, S. C. Robson, H. Osswald and H. K. Eltzschig: Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J, 21(11), 2863-73 (2007)
25. D. R. Freyer, L. A. Boxer, R. A. Axtell and R. F. Todd, 3rd: Stimulation of human neutrophil adhesive properties by adenine nucleotides. J Immunol, 141(2), 580-6 (1988)
26. G. K. Akbar, D. C. Mills and S. P. Kunapuli: Characterization of extracellular nucleotide-induced Mac-1 (alphaM beta2 integrin) surface expression on peripheral blood leukocytes. Biochem Biophys Res Commun, 233(1), 71-5 (1997)
27. D. C. Altieri, W. L. Wiltse and T. S. Edgington: Signal transduction initiated by extracellular nucleotides regulates the high affinity ligand recognition of the adhesive receptor CD11b/CD18. J Immunol, 145(2), 662-70 (1990)
28. N. Mizumoto, T. Kumamoto, S. C. Robson, J. Sevigny, H. Matsue, K. Enjyoji and A. Takashima: CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med, 8(4), 358-65 (2002)
29. R. D. Granstein, W. Ding, J. Huang, A. Holzer, R. L. Gallo, A. Di Nardo and J. A. Wagner: Augmentation of cutaneous immune responses by ATPgammaS: purinergic agonists define a novel class of immunologic adjuvants. J Immunol, 174, 7725-31 (2005)
30. M. Idzko, H. Hammad, M. van Nimwegen, M. Kool, M. A. M. Willart, F. Muskens, H. C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, J. C. Virchow Jr and B. N. Lambrecht: Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med, 13(8), 913-9 (2007)
31. T. Muller, R. Paula Vieira, M. Grimm, T. Durk, S. Cicko, R. Zeiser, T. Jakob, S. F. Martin, B. Blumenthal, S. Sorichter, D. Ferrari, F. Di Virgilio and M. Idzko: A Potential Role for P2X7R in Allergic Airway Inflammation in Mice and Humans. Am J Respir Cell Mol Biol, in press (2010)
32. N. Riteau, P. Gasse, L. Fauconnier, A. Gombault, M. Couegnat, L. Fick, J. Kanellopoulos, V. F. J. Quesniaux, S. Marchand-Adam, B. Crestani, B. Ryffel and I. Couillin: Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med, 182, 774-83 (2010)
33. T. Eckle, L. Fullbier, M. Wehrmann, J. Khoury, M. Mittelbronn, J. C. Ibla, P. Rosenberger and H. K. Eltzschig: Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol, 178, 8127-37 (2007)
34. J. Reutershan, I. Vollmer, S. Stark, R. Wagner, K. C. Ngamsri and H. K. Eltzschig: Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J, 23, 473-82 (2009)
35. E. Mortaz, S. Braber, M. Nazary, M. E. Givi, F. P. Nijkamp and G. Folkerts: ATP in the pathogenesis of lung emphysema. Eur J Pharmacol, 619, 92-6 (2009)
36. E. Mortaz, G. Folkerts, F. P. Nijkamp and P. A. J. Henricks: ATP and the pathogenesis of COPD. Eur J Pharmacol, 638, 1-4 (2010)
37. S. Cicko, M. Lucattelli, T. Muller, M. Lommatzsch, G. De Cunto, S. Cardini, W. Sundas, M. Grimm, R. Zeiser, T. Durk, G. Zissel, J.-M. Boeynaems, S. Sorichter, D. Ferrari, F. Di Virgilio, J. C. Virchow, G. Lungarella and M. Idzko: Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol, 185, 688-97 (2010)
38. M. Lucattelli, S. Cicko, T. Muller, M. Lommatzsch, G. De Cunto, S. Cardini, W. Sundas, M. Grimm, R. Zeiser, T. Durk, G. Zissel, S. Sorichter, D. Ferrari, F. Di Virgilio, J. C. Virchow, G. Lungarella and M. Idzko: P2X7 Receptor Signalling in the Pathogenesis of Smoke-induced Lung Inflammation and Emphysema. Am J Respir Cell Mol Biol, in press (2010)
39. M. Lommatzsch, S. Cicko, T. Muller, M. Lucattelli, K. Bratke, P. Stoll, M. Grimm, T. Durk, G. Zissel, D. Ferrari, F. Di Virgilio, S. Sorichter, G. Lungarella, J. C. Virchow and M. Idzko: Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 181, 928-34 (2010)
40. G. Hasko and B. N. Cronstein: Adenosine: an endogenous regulator of innate immunity. Trends Immunol, 25(1), 33-9 (2004)
41. B. B. Fredholm: Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ, 14(7), 1315-23 (2007)
42. V. Medved: Recognition of microorganisms and activation of the immune response. Nature, 449, 819-26 (2007)
43. H. Kumar, T. Kawai and S. Akira: Pathogen recognition in the innate immune response. Biochem J, 420, 1-16 (2009)
44. F. Martinon, A. Mayor and J. Tschopp: The inflammasomes: guardians of the body. Annu Rev Immunol, 27, 229-65 (2009)
45. S. Mariathasan, K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson and V. M. Dixit: Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature, 430, 213-8 (2004)
46. S. Mariathasan, D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, D. M. Monack and V. M. Dixit: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature, 440, 228-32 (2006)
47. D. Perregaux and C. A. Gabel: Interleukin-1 beta maturation and release in response to AT P and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem, 269(21), 15195-203 (1994)
48. D. Ferrari, M. Villalba, P. Chiozzi, S. Falzoni, P. Ricciardi- Castagnoli and F. Di Virgilio: Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol, 156(4), 1531-9 (1996)
49. P. Pelegrin, C. Barroso-Gutierrez and A. Surprenant: P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol, 180, 7147-57 (2008)
50. V. Petrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon and J. Tschopp: Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Diff, 14, 1583-9 (2007)
51. C. M. Cruz, A. Rinna, H. J. Forman, A. L. M. Ventura, P. M. Persechini and D. M. Ojcius: ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem, 282(5), 2871-9 (2007)
52. A. Piccini, S. Carta, S. Tassi, D. Lasiglie, G. Fossati and A. Rubartelli: ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A, 105(23), 8067-72 (2008)
53. F. Ghiringhelli, L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma, C. Ortiz, K. Vermaelen, T. Panaretakis, G. Mignot, E. Ullrich, J. L. Perfettini, F. Schlemmer, E. Tasdemir, M. Uhl, P. Genin, A. Civas, B. Ryffel, J. Kanellopoulos, J. Tschopp, F. Andre, R. Lidereau, N. M. McLaughlin, N. M. haynes, M. J. Smyth, G. Kroemer and L. Zitvogel: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med, 15(10), 1170-8 (2009)
54. S. S. Iyer, W. P. Pulskens, J. J. Sadler, L. M. Butter, G. J. Teske, T. K. Ulland, S. C. Eisenbarth, S. Florquin, R. A. Flavell, J. C. Leemans and F. S. Sutterwala: Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A, 106(48), 20388-93 (2009)
55. S. L. Masters, A. Simon, I. Aksentijevich and D. L. Kastner: Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol, 27, 621-68 (2009)
56. M. Colina, C. Pizzirani, M. Khodeir, S. Falzoni, M. Bruschi, F. Trotta and F. Di Virgilio: Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology, 49(7), 1416-8 (2010)
57. C. Pizzirani, S. Falzoni, M. Govoni, R. La Corte, S. Donadei, F. Di Virgilio, F. Trotta and A. Lo Monaco: Dysfunctional inflammasome in Schnitzler's syndrome. Rheumatology, 48(10), 1304-8 (2009)
58. M. Gattorno, S. Tassi, S. Carta, L. Delfino, F. Ferlito, M. A. Pellegatti, D'Osualdo, A., A. Buoncompagni, M. G. Alpigiani, M. Alessio, A. Martini and A. Rubartelli: Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum, 56(9), 3138-48 (2007)
59. M. Solle, J. Labasi, D. G. Perregaux, E. Stam, N. Petrushova, B. H. Koller, R. J. Griffiths and C. A. Gabel: Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem, 276(1), 125-32 (2001)
60. J. M. Labasi, N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M. M. Payette, W. Brissette, J. R. Wicks, L. Audoly and C. A. Gabel: Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol, 168(12), 6436-45 (2002)
61. L. Aymeric, L. Apetoh, F. Ghiringhelli, A. Tesniere, I. Martins, G. Kroemer, M. J. Smyth and L. Zitvogel: Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res, 70(3), 855-8 (2010)
62. H. Gunosewoyo and M. Kassiou: P2X purinergic receptor ligands: recently patented compounds. Expert Opin Ther Patents, 20(5), 625-46 (2010)
63. S. D. Guile, L. Alcaraz, T. N. Birkinshaw, K. C. Bowers, M. R. Ebden, M. Furber and M. J. Stocks: Antagonists of the P2X7 receptor. From lead identification to drug development. J Med Chem, 52(10), 3123-41 (2009)
64. W. A. Carroll, D. Donnely-Roberts and M. F. Jarvis: Selective P2X7 receptor antagonists for chronic inflammation and pain. Purinergic Signal, 5(1), 63-73 (2009)
65. J. M. Boeynaems and D. Communi: Modulation of inflammation by extracellular nucleotides. J Invest Dermatol, 126(5), 943-4 (2006)
66. P. Pelegrin and A. Surprenant: Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1-beta release through pyrophosphates. EMBO J, 28(14), 2114-27 (2009)
67. R. D. Stout and J. Suttles: Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol, 76(3), 509-13 (2004)
68. G. Hasko, D. G. Kuhel, A. L. Salzman and C. Szabo: ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages. Br J Pharmacol, 129(5), 909-914 (2000)
69. A. Kaufmann, B. Musset, S. H. Limberg, V. Renigunta, R. Sus, A. H. Dalpke, K. M. Heeg, B. Robaye and P. J. Hanley: "Host tissue damage" signal ATP promotes nondirectional migration and negatively regulates Toll-like receptor signaling in human monocytes. J Biol Chem, 280(37), 32459-67 (2005)
70. A. la Sala, D. Ferrari, S. Corinti, A. Cavani, F. Di Virgilio and G. Girolomoni: Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol, 166(3), 1611-7 (2001)
71. F. Wilkin, P. Stordeur, M. Goldman, J. M. Boeynaems and B. Robaye: Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur J Immunol, 32(9), 2409-17 (2002)
72. A. la Sala, S. Sebastiani, D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer and G. Girolomoni: Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood, 99(5), 1715-22 (2002)
73. F. Wilkin, X. Duhant, C. Bruyns, N. Suarez-Huerta, J. M. Boeynaems and B. Robaye: The P2Y11 receptor mediates the ATP-induced maturation of human monocytederived dendritic cells. J Immunol, 166(12), 7172-7 (2001)
74. M. Schnurr, T. Toy, P. Stoitzner, P. Cameron, A. Shin, T. Beecroft, I. D. Davis, J. Cebon and E. Maraskovsky: ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood, 102(2), 613-20 (2003)
75. D. R. Meldrum, A. Ayala, P. Wang, W. Ertel and I. H. Chaudry: Association between decreased splenic ATP levels and immunodepression: amelioration with ATP-MgCl2. Am J Physiol, 261(2 Pt 2), R351-7 (1991)
76. P. Wang, Z. F. Ba, M. H. Morrison, A. Ayala, R. E. Dean and I. H. Chaudry: Mechanism of the beneficial effects of ATP-MgCl2 following trauma-hemorrhage and resuscitation: downregulation of inflammatory cytokine (TNF, IL-6) release. J Surg Res, 52(4), 364-71 (1992)
77. D. R. Meldrum, A. Ayala and I. H. Chaudry: Energetics of defective macrophage antigen presentation after hemorrhage as determined by ultraresolution 31P nuclear magnetic resonance spectrometry: restoration with adenosine triphosphate-MgCl2. Surgery, 112(2), 150-6 (1992)
78. D. R. Meldrum, A. Ayala and I. H. Chaudry: Energetics of lymphocyte " burnout" in late sepsis: adjuvant treatment with ATP-MgCl2 improves energetics and decreases lethality. J Surg Res, 56, 537-42 (1994)
79. I. H. Chaudry: Use of ATP following shock and ischemia. Ann N Y Acad Sci, 603, 130-40; discussion 140-1 (1990)
80. E. L. R. Swennen, A. Bast and P. C. Dagnelie: Immunoregulatory effects of adenosine 5'-triphosphate on cytokine release from stimulated whole blood. Eur J Immunol, 35(3), 852-8 (2005)
81. E. L. R. Swennen, E. J. C. M. Coolen, I. C. W. Arts, A. Bast and P. C. Dagnelie: Time-dependent effects of ATP and its degradation products on inflammatory markers in human blood ex vivo. Immunobiology, 213(5), 389-97 (2008)
82. E. L. R. Swennen, P. C. Dagnelie, T. Van den Beucken and A. Bast: Radioprotective effects of ATP in human blood ex vivo. Biochem Biophys Res Commun, 367(2), 383-7 (2008)
83. E. L. R. Swennen, A. Bast and P. C. Dagnelie: Purinergic receptors involved in the immunomodulatory effects of ATP in human blood. Biochem Biophys Res Commun, 348(3), 1194-9 (2006)
84. M. J. Bours, H. R. M. Peeters, R. B. M. Landewe, S. Beijer, I. C. W. Arts and P. C. Dagnelie: ATP infusions reduced disease activity and inflammation in a patient with active rheumatoid arthritis: a case report. Rheumatology, 49 (11), 2223-5 (2010)
85. G. Burnstock: Purinergic nerves. Pharmacol Rev, 24(3), 509-81 (1972)
86. F. Di Virgilio, V. Bronte, D. Collavo and P. Zanovello: Responses of mouse lymphocytes to extracellular adenosine 5'- triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP. J Immunol, 143(6), 1955-60 (1989)
87. J. S. Wiley and G. R. Dubyak: Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood, 73(5), 1316-23 (1989)
88. A. Filippini, R. E. Taffs, T. Agui and M. V. Sitkovsky: Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP. J Biol Chem, 265(1), 334-40 (1990)
89. S. Honda, Y. Sasaki, K. Ohsawa, Y. Imai, Y. Nakamura, K. Inoue and S. Kohsaka: Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci, 21(6), 1975-82 (2001)
90. M. Idzko, S. Dichmann, D. Ferrari, F. Di Virgilio, A. La Sala, G. Girolomoni, E. Panther and J. Norgauer: Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood, 100(3), 925-932 (2002)
91. C. Mutini, S. Falzoni, D. Ferrari, P. Chiozzi, A. Morelli, O. R. Baricordi, G. Collo, P. Ricciardi-Castagnoli and F. Di Virgilio: Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol, 163(4), 1958-65 (1999)
92. O. R. Baricordi, D. Ferrari, L. Melchiorri, P. Chiozzi, S. Hanau, E. Chiari, M. Rubini and F. Di Virgilio: An ATPactivated channel is involved in mitogenic stimulation of human T lymphocytes. Blood, 87(2), 682-90 (1996)
93. M. Tsuda, Y. Shigemoto-Mogami, S. Koizumi, S. Kohsaka, M. W. Salter and K. Inoue: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve inju. Nature, 424(6950), 778-83 (2003)
94. J. Rho, M. Takami and Y. Choi: Osteoimmunology: interactions of the immune and skeletal systems. Mol Cells, 17(1), 1-9 (2004)
95. L. J. Raggatt and N. C. Partridge: Cellular and molecular mechanims of bone remodelling. J Biol Chem, 285(33), 25103-8 (2010)
96. J. Korcok, L. N. Raimundo, X. Du, S. M. Sims and S. J. Dixon: P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem, 280(17), 16909-15 (2005)
97. P. Luckprom, S. Wongkhantee, T. Yongchaitrakkul and P. Pavasant: Adenosine triphosphate stimulates RANKL expression through P2Y1 receptor-cyclo-oxygenasedependent pathway in human periodontal ligament cells. J Periodontal Res, 45(3), 404-11 (2010)
98. I. R. Orriss, G. Burnstock and T. R. Arnett: Purinergic signalling and bone remodelling. Curr Opin Pharmacol, 10(3), 322-30 (2010)
99. H. J. Agteresch, P. C. Dagnelie, A. van der Gaast, T. Stijnen and J. H. Wilson: Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced nonsmall- cell lung cancer. J Natl Cancer Inst, 92(4), 321-328 (2000)
100. P. C. Dagnelie and H. J. Agteresch: Promising effects of adenosine triphosphate infusion on nutritional status and quality of life in advanced non-small-cell lung cancer: a randomized clinical trial. Drug Dev Res, 59, 146-51 (2003)
101. H. J. Agteresch, P. C. Dagnelie, T. Rietveld, J. W. van den Berg, A. H. Danser and J. H. Wilson: Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol, 56(1), 49-55 (2000)
102. M. Sridharan, S. P. Adderley, E. A. Bowles, T. M. Egan, A. H. Stephenson, M. L. Ellsworth and R. S. Sprague: Pannexin 1 is the conduit for low oxygen tensioninduced ATP release from human erythrocytes. Am J Phsyiol Heart Circ Physiol, 299(4), H1146-52 (2010)
103. M. L. Ellsworth, C. G. Ellis, D. Goldman, A. H. Stephenson, H. H. Dietrich and R. S. Sprague: Erythrocytes: oxygen sensors and modulators of vascular Physiology (Bethesda), 24, 107-16 (2009)
104. J. Wan, W. D. Ristenpart and H. A. Stone: Dynamics of shear-induced ATP release from red blood cells. Proc Natl Acad Sci U S A, 105(43), 16432-7 (2008)